Coverage
-
March 26, 2019
Johnson & Johnson has beaten Walgreens and Kroger's lawsuit alleging it snuffed out competition for its arthritis treatment Remicade and jacked up prices, leaving one fewer trial for the drugmaker to face amid a sprawling antitrust battle over Remicade's market dominance.
5 other articles on this case.
View all »